Back
BioMarin Pharmaceutical, Inc. Stock Predictions
Know when to buy, sell, or hold. Rate Any Stock In Seconds
Get Your Free Stock Analysis Now
Sell
47
BMRN
BioMarin Pharmaceutical, Inc.
Last Price:
$56.85
Seasonality Move:
-1.65%
7 Day Trial
ALL ACCESS PASS
$
7
Color-coded buy, sell, hold signals make stock decisions simple.
Get Your Free Stock Analysis NowBioMarin Pharmaceutical, Inc. Stock Forecast
-
Over the next 52 weeks, BioMarin Pharmaceutical, Inc. has on average historically risen by 11.2% based on the past 26 years of stock performance.
-
BioMarin Pharmaceutical, Inc. has risen higher in 14 of those 26 years over the subsequent 52-week period, corresponding to a historical accuracy of 53.85%
-
Is BioMarin Pharmaceutical, Inc. Stock Undervalued?The current BioMarin Pharmaceutical, Inc. [BMRN] share price is $56.85. The Score for BMRN is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
-
BMRN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will BioMarin Pharmaceutical, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, BioMarin Pharmaceutical, Inc. has on average historically risen by 11.2% based on the past 26 years of stock performance.
BioMarin Pharmaceutical, Inc. Stock Rating
Sell
47
BioMarin Pharmaceutical, Inc. (BMRN)
is a Sell
Is BioMarin Pharmaceutical, Inc. overpriced?
-
BioMarin Pharmaceutical, Inc. has risen higher in 14 of those 26 years over the subsequent 52-week period, corresponding to a historical accuracy of 53.85%
BioMarin Pharmaceutical, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
biomarin.com
52-Week Data
52-Week High:
73.51
52-Week Low:
50.76
Prediction Charts
Market Cap:
10.9B
Price in USD:
56.85
Volume:
1.3M
Beta:
0.84
Technical Analysis
SMA50:
55.99
SMA100:
54.99
SMA200:
56.67
52-Wk Change:
-8.01%
Stock Predictions
-
Is BioMarin Pharmaceutical, Inc. stock public?Yes, BioMarin Pharmaceutical, Inc. is a publicly traded company.
-
What is the BioMarin Pharmaceutical, Inc. stock quote today?The BioMarin Pharmaceutical, Inc. stock price is 56.85 USD today.
-
How to buy BioMarin Pharmaceutical, Inc. stock online?You can buy BioMarin Pharmaceutical, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Jan-7 | 60.50 | 61.31 | 61.88 | 60.34 |
| Jan-8 | 61.00 | 60.35 | 61.28 | 59.80 |
| Jan-9 | 60.52 | 58.95 | 60.80 | 58.85 |
| Jan-12 | 58.96 | 57.71 | 59.03 | 57.27 |
| Jan-13 | 57.82 | 55.20 | 57.95 | 54.36 |
| Jan-14 | 55.44 | 56.08 | 56.37 | 55.20 |
| Jan-15 | 56.23 | 55.07 | 56.35 | 54.81 |
| Jan-16 | 55.00 | 54.59 | 55.23 | 54.58 |
| Jan-20 | 54.73 | 56.31 | 56.42 | 54.07 |
| Jan-21 | 56.31 | 56.77 | 57.24 | 56.03 |
| Jan-22 | 56.74 | 57.18 | 58.33 | 56.36 |
| Jan-23 | 57.14 | 56.21 | 57.19 | 56.10 |
| Jan-26 | 55.82 | 56.78 | 57.31 | 55.50 |
| Jan-27 | 56.60 | 56.85 | 57.15 | 56.16 |
BioMarin Pharmaceutical, Inc. Earnings
BioMarin Pharmaceutical, Inc. Earnings Report: Per Share BioMarin Pharmaceutical, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
BioMarin Pharmaceutical, Inc. Forecast Revenue Growth
BioMarin Pharmaceutical, Inc. Stock Analysis: Historical quarterly revenues per share for BioMarin Pharmaceutical, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.98 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.84 per share, and an increase next year of $0.55 per share.
* BioMarin Pharmaceutical, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.